These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1271103)

  • 21. Application of the Food and Drug Administration's current good manufacturing practices regulations to pharmacy practice: a legal view.
    Fink JL
    Contemp Pharm Pract; 1979; 2(4):202-5. PubMed ID: 10244540
    [No Abstract]   [Full Text] [Related]  

  • 22. Preclearance of drug products--pharmacy's perspective.
    Feldmann EG
    Am Pharm; 1981 Jun; NS21(6):26-32. PubMed ID: 7246421
    [No Abstract]   [Full Text] [Related]  

  • 23. Editorial: Is the FDA too fearsome?
    Berry FB
    Med Times; 1973 Oct; 101(10):15 passim. PubMed ID: 4755498
    [No Abstract]   [Full Text] [Related]  

  • 24. An interview with FDA commissioner Hayes.
    Small WE
    Am Pharm; 1981 Oct; NS21(10):27-36. PubMed ID: 6803557
    [No Abstract]   [Full Text] [Related]  

  • 25. Standing on your own feet.
    Apple WS
    J Am Pharm Assoc; 1974 Jun; 14(6):278-80. PubMed ID: 4840422
    [No Abstract]   [Full Text] [Related]  

  • 26. Editorial: The FDA and the supreme court.
    Dornette WH
    J Indiana State Med Assoc; 1974 Feb; 67(2):121-2. PubMed ID: 4812470
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacy compounding: customizing prescription drugs.
    Nordenberg T
    FDA Consum; 2000; 34(4):11-2. PubMed ID: 11924628
    [No Abstract]   [Full Text] [Related]  

  • 28. Application of standards for compounding.
    Newton DW
    J Am Vet Med Assoc; 1994 Jul; 205(2):232-4. PubMed ID: 7928584
    [No Abstract]   [Full Text] [Related]  

  • 29. Regulation of mail-order pharmacy.
    Munro GS
    J Leg Med; 1991 Mar; 12(1):1-58. PubMed ID: 1856589
    [No Abstract]   [Full Text] [Related]  

  • 30. Compliance Policy Guide on Chapter 4 Human Drugs: Section 460.200 Pharmacy Compounding.
    J Pain Palliat Care Pharmacother; 2003; 17(1):99-106. PubMed ID: 14640347
    [No Abstract]   [Full Text] [Related]  

  • 31. Improving and enforcing compounding pharmacy practices to protect patients.
    Pegues DA
    Clin Infect Dis; 2006 Oct; 43(7):838-40. PubMed ID: 16941363
    [No Abstract]   [Full Text] [Related]  

  • 32. Should the FDA control medical devices?
    Ariz Med; 1968 Sep; 25(9):814-5. PubMed ID: 5680263
    [No Abstract]   [Full Text] [Related]  

  • 33. ASHP statement on hospital drug control systems.
    Am J Hosp Pharm; 1974 Dec; 31(12):1198-207. PubMed ID: 4458439
    [No Abstract]   [Full Text] [Related]  

  • 34. The patient package insert and its legal implications.
    Cook D
    Leg Med Q; 1980; 4():258-70. PubMed ID: 10258797
    [No Abstract]   [Full Text] [Related]  

  • 35. Governance of pharmacy, 1952-2002.
    Brushwood DB
    J Am Pharm Assoc (Wash); 2002; 42(3):383-4. PubMed ID: 12030622
    [No Abstract]   [Full Text] [Related]  

  • 36. Editorial: FDA--approved?
    Collins CM
    J Fla Med Assoc; 1974 Jun; 61(6):458-9. PubMed ID: 4831239
    [No Abstract]   [Full Text] [Related]  

  • 37. President signs compounding law.
    Traynor K
    Am J Health Syst Pharm; 2014 Jan; 71(1):7. PubMed ID: 24352171
    [No Abstract]   [Full Text] [Related]  

  • 38. Compounding for human use in the future.
    Myers CE
    J Am Vet Med Assoc; 1994 Jul; 205(2):292-4. PubMed ID: 7928604
    [No Abstract]   [Full Text] [Related]  

  • 39. Annual administrative reviews: pharmacy.
    Black HJ
    Hospitals; 1973 Apr; 47(7):153-5 passim. PubMed ID: 4573778
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of a course of study in FDA drug regulatory procedures.
    Jacobs RW; King JC
    Am J Pharm Educ; 1977 May; 41(2):185-88. PubMed ID: 10236647
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.